Showing results (1331-1340 of 2,067) with videos related to

Sort By:
Pageof 207
Kidney & Blood Pressure Research|January 14, 2020
Oct-4 Enhanced the Therapeutic Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Acute Kidney InjuryZhi-Yuan Zhang, Yan-Ping Hou, Xiang-Yu Zou, et al.
Kidney & Blood Pressure Research|March 15, 2018
CTLA-4 Polymorphisms in Patients with IgA Nephropathy Correlate with ProteinuriaMarius Jacob, Kim Ohl, Tannaz Goodarzi, et al.
Kidney & Blood Pressure Research|March 15, 2018
Risk Factors of Renal Involvement Based on Different Manifestations in Patients with Ankylosing SpondylitisYan Wu, Guangli Zhang, Niansong Wang, et al.
Kidney & Blood Pressure Research|December 23, 2019
The Effect of Urine pH and Urinary Uric Acid Levels on the Development of Contrast NephropathyGamze Aslan, Baris Afsar, Alan A Sag, et al.
Kidney & Blood Pressure Research|April 4, 2006
Cystatin C--a marker for assessment of the glomerular filtration rate in patients with cisplatin chemotherapyP Benöhr, A Grenz, J T Hartmann, et al.
Kidney & Blood Pressure Research|April 4, 2006
Mice lacking protein kinase C beta present modest increases in systolic blood pressure and NH4Cl-induced metabolic acidosisLi-Jun Yao, Michael Leitges, Volker Vallon
Kidney & Blood Pressure Research|May 3, 2006
Effects of anesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive ratsZuzana Husková, Herbert J Kramer, Monika Thumová, et al.
Kidney & Blood Pressure Research|April 29, 2006
Does the hyperfiltration of minoxidil result in increased proteinuria and loss of renoprotection conferred by angiotensin inhibition?Charles J Diskin, Thomas J Stokes, Linda M Dansby, et al.
Kidney & Blood Pressure Research|July 27, 2004
Identifying chemokines as therapeutic targets in renal disease: lessons from antagonist studies and knockout miceVolker Vielhauer, Vaclav Eis, Detlef Schlöndorff, et al.
Kidney & Blood Pressure Research|July 27, 2005
Prospective comparison of valacyclovir and oral ganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipientsTomás Reischig, Karel Opatrný, Vladislav Treska, et al.
Pageof 207